Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Rosen

Showing results (31-40 of 207) with videos related to

Pageof 21
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Synthesis of novel fluorescent probes for the molecular chaperone Hsp90Laura Llauger-Bufi, Sara J Felts, Henri Huezo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PETPeter M Smith-Jones, David Solit, Farzana Afroze, et al.
Blood|September 28, 2002
BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90Mercedes E Gorre, Katharine Ellwood-Yen, Gabriela Chiosis, et al.
Journal of Biomolecular Screening|August 7, 2004
Development of a fluorescence polarization assay for the molecular chaperone Hsp90Joungnam Kim, Sara Felts, Laura Llauger, et al.
The Journal of Biological Chemistry|August 15, 2002
Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 functionAndrea D Basso, David B Solit, Gabriela Chiosis, et al.
Cancer Research|May 3, 2003
Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to TaxolDavid B Solit, Andrea D Basso, Adam B Olshen, et al.
Magnetic Resonance in Medicine|September 26, 2009
Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22rH Carl Le, Mihaela Lupu, Khushali Kotedia, et al.
Nature Structural & Molecular Biology|May 13, 2014
PTEN is a protein tyrosine phosphatase for IRS1Yuji Shi, Junru Wang, Sarat Chandarlapaty, et al.
Nature Reviews. Materials|December 24, 2021
Targeted drug delivery strategies for precision medicinesMandana T Manzari, Yosi Shamay, Hiroto Kiguchi, et al.
Journal of the American Chemical Society|June 24, 2004
New efficient synthesis of resorcinylic macrolides via ynolides: establishment of cycloproparadicicol as synthetically feasible preclinical anticancer agent based on Hsp90 as the targetZhi-Qiang Yang, Xudong Geng, David Solit, et al.
Pageof 21

Showing results (31-40 of 207) with videos related to

Sort By:
Pageof 21
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Synthesis of novel fluorescent probes for the molecular chaperone Hsp90Laura Llauger-Bufi, Sara J Felts, Henri Huezo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PETPeter M Smith-Jones, David Solit, Farzana Afroze, et al.
Blood|September 28, 2002
BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90Mercedes E Gorre, Katharine Ellwood-Yen, Gabriela Chiosis, et al.
Journal of Biomolecular Screening|August 7, 2004
Development of a fluorescence polarization assay for the molecular chaperone Hsp90Joungnam Kim, Sara Felts, Laura Llauger, et al.
The Journal of Biological Chemistry|August 15, 2002
Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 functionAndrea D Basso, David B Solit, Gabriela Chiosis, et al.
Cancer Research|May 3, 2003
Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to TaxolDavid B Solit, Andrea D Basso, Adam B Olshen, et al.
Magnetic Resonance in Medicine|September 26, 2009
Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22rH Carl Le, Mihaela Lupu, Khushali Kotedia, et al.
Nature Structural & Molecular Biology|May 13, 2014
PTEN is a protein tyrosine phosphatase for IRS1Yuji Shi, Junru Wang, Sarat Chandarlapaty, et al.
Nature Reviews. Materials|December 24, 2021
Targeted drug delivery strategies for precision medicinesMandana T Manzari, Yosi Shamay, Hiroto Kiguchi, et al.
Journal of the American Chemical Society|June 24, 2004
New efficient synthesis of resorcinylic macrolides via ynolides: establishment of cycloproparadicicol as synthetically feasible preclinical anticancer agent based on Hsp90 as the targetZhi-Qiang Yang, Xudong Geng, David Solit, et al.
Pageof 21